Doctors News Hubb
Advertisement Banner
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
Doctors News Hubb
No Result
View All Result
Home News

DNA Methylation Profiling in the Blood for Ovarian Cancer Screening

admin by admin
November 29, 2022
in News


Due to insufficient early detection methods, ovarian cancer remains a leading cause of death among gynecological malignancies. Therefore, DNA methylation profiling in blood samples was investigated for its potential in detecting ovarian cancer in this study. Blood samples (n = 373) and tissue samples (n = 152) from healthy women, women with benign ovarian tumors, and women with malignant epithelial ovarian tumors were subjected to targeted bisulfite sequencing. 

To forecast and categorize each blood sample as malignant or non-malignant, a supervised machine-learning system was constructed and cross-validated using the DNA methylation profiles of the training cohort (n = 178). A separate test cohort (n = 184) was used to assess the model. Further, there were 1,272 differentially methylated sites were found after comparing DNA methylation profiles of benign and malignant tumor samples; 49.4% of these regions were hypermethylated, and 50.6% were hypomethylated. The area under the curve for the model in the training dataset was 0.94 when researchers performed 5-fold cross-validation. 

The algorithm correctly identified benign tumors in the test dataset in 93.5% of women with benign tumors (n = 46) and 96.2% of healthy women (n = 53). The model correctly identified malignancy in 44.4% of stage I-II (n = 9), 86.4% of stage III (n = 59), 100% of stage IV (n = 6), and 81.8% of stage unknown (n = 11) tumors in patients with malignant tumors. The overall prediction accuracy of the model was 89.5%. These results show that DNA methylation profiling in blood could be used clinically to screen for ovarian cancer.

Source: sciencedirect.com/science/article/abs/pii/S0090825822004802



Source link

Advertisement Banner
Previous Post

Pipeline reaches deal to sell Weiss, West Suburban hospitals

Next Post

AJ Loiacono, CEO, CapitalRx – The Health Care Blog

Related Posts

News

Treatment of Older Adults’ Constipation Caused by Opioids

February 7, 2023
News

Serious Illness: Advance Care Planning

February 6, 2023
News

Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality

February 5, 2023
News

#VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension

February 4, 2023
News

Risk of Severe COVID-19 Infection and Other SARIs in Preexisting Neuropsychiatric Conditions

February 3, 2023
News

Vitiligo Responding and Refractory Alopecia Areata During the Monotherapy With Tofacitinib

February 2, 2023
Next Post

AJ Loiacono, CEO, CapitalRx – The Health Care Blog

Recommended

988 mental health hotline resumes after national service outage

2 months ago

Health system mergers, acquisitions likely in growing markets

2 months ago

How to Sleep on a Plane: Tips & Products to Help

3 months ago

Travel Nursing Demand Is Waning: Now Hospitals Want Full-Time Nurses Back

3 months ago

ER Nurse Follows Protocol, Avoids Negligence Lawsuit

1 month ago

© 2022 Doctors News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

© 2022 Doctors News Hubb All rights reserved.